SC
Synergy CHC Corp. (SNYR)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 delivered ninth consecutive profitable quarter: revenue $8.17M, gross margin 75.4%, operating income $1.95M, net income $0.88M, diluted EPS $0.10; EBITDA $1.98M, with EBITDA margin expanding to 24.1% .
- Versus consensus: EPS beat ($0.10 vs $0.07), while revenue missed ($8.17M vs $9.03M). The EPS beat was driven by lower OpEx and mix-driven margin expansion; the revenue miss reflects lapping a one-time sell-in that did not repeat in 2025 (bold indicates magnitude for traders) .
- Strategic catalysts: $1.5M UAE licensing fee (Q1) with revenue expected to begin in Q4; Amazon POs of nearly $1M for RTD beverages in Q2 with full rollout in 2H; long-term supplier agreement for FOCUSfactor shifting inventory ownership to supplier, driving cost savings .
- Balance sheet actions and outlook: entered term sheets to refinance debt, extending maturities to 2029 and expected to alleviate >$10M of principal payments in 2025, accelerating near‑term FCF; cash at quarter‑end was $0.18M; total liabilities reduced by $1.7M sequentially .
What Went Well and What Went Wrong
What Went Well
- Margin and EPS execution: “30% growth in earnings per share year‑over‑year… expanded our EBITDA margins significantly to 24.1% vs. 19.7% in the prior year period” (CEO) .
- Licensing and international expansion: $1.5M UAE license fee booked in Q1; Mexico subsidiary established with Costco/Walmart onboarding; Australia and Taiwan targeted for Q4 openings (Costco lead) .
- RTD commercialization momentum: nearly $1M in Amazon POs in Q2 and >400 additional convenience stores opened in Canada; industry veteran hired to scale beverages .
What Went Wrong
- Top-line decline and revenue miss vs. consensus: revenue fell 13% YoY to $8.17M due to a 2024 one-time sell-in not repeating; consensus had expected ~$9.03M (miss) .
- Cash and working capital pressure: cash and equivalents declined to $0.18M; operating cash flow was negative $0.82M in Q1, driven by inventory build and reduction in payables .
- Continued leverage and interest burden: interest expense was $1.10M in Q1; sequential liquidity tightness underscores urgency of refinancing .
Financial Results
Segment/Revenue Composition (Q1 2025):
Balance Sheet KPIs (quarter-end):
Non-GAAP reconciliation (Q1 2025):
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We are very pleased to report 30% growth in earnings per share year-over-year, marking our ninth consecutive quarter of profitability… expanded our EBITDA margins significantly to 24.1%” (CEO, Jack Ross) .
- On RTD: “We received nearly $1 million of purchase orders from Amazon… expect to be in full rollout mode with Amazon and other major retailers in the back half of the year” .
- On licensing: “We signed a licensee for the United Arab Emirates… we received a fee for $1.5 million… expect to start generating revenue in the fourth quarter” .
- On cost structure: “Long-term supplier agreement… supplier now owning the inventory and shipping directly… significant cost saving benefits” .
- On debt: “Entered into 2 term sheets to refinance… expected to accelerate free cash flow… alleviate more than $10 million of principal payments in 2025… extend maturity… into 2029” .
Q&A Highlights
- RTD trajectory: Q1 RTD revenue ~$30k;
$()$2M expected in Q2 driven by Amazon; focus on U.S./Canada convenience stores and existing retail network . - Expense framework: G&A expected to be “pretty flat” as a percentage, with minor headcount additions .
- Licensing revenue: $1.5M UAE upfront fee recognized in Q1; future revenue based on sales in territory beginning Q4 .
- Geographic clarifications: New markets targeted for Australia and Taiwan (not Thailand) .
Estimates Context
Values retrieved from S&P Global.
Key Takeaways for Investors
- Execution drove an EPS beat despite revenue headwinds; margin expansion and OpEx discipline were decisive this quarter .
- Near‑term trading catalyst: RTD commercialization (Amazon + convenience channels) and international licensing revenue commencement in Q4 provide tangible 2H acceleration vectors .
- Structural cost improvements via supplier agreement should support sustained gross margin and reduce working capital intensity .
- Balance sheet remains leveraged with low cash; successful refinancing (to 2029) would materially de‑risk 2025 cash needs and free cash flow trajectory .
- Q1 revenue miss reflects non-recurring 2024 sell‑in; watch for sequential recovery as de‑inventorying is behind them and RTD ramps .
- Flat Tummy’s GLP‑1 adjacency and retail expansion broaden growth optionality beyond core FOCUSfactor .
- Estimates likely to adjust: upward on EPS (margin visibility, refinancing) and potentially lower/normalized on near‑term revenue until RTD ramps are evidenced in Q2/Q3 prints (consensus coverage is thin) .